Skip to main content
Adastra Holdings logo

Adastra Holdings — Investor Relations & Filings

Ticker · XTRX ISIN · CA00654D2095 LEI · 549300SKMLMH3FJ3AF32 CSE Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2025-01-21 Board/Management Inform…
Country CA Canada
Listing CSE XTRX

About Adastra Holdings

https://adastraholdings.ca/

Adastra Holdings is a manufacturer and supplier of ethnobotanical and cannabis products for the lawful adult-use and medical markets. The company specializes in the extraction and processing of cannabis, offering a portfolio that includes concentrates, vape pens, wax, resin, and infused pre-rolls. Adastra manufactures products for its proprietary brands, such as Phyto Extractions and Endgame Extracts, and provides co-manufacturing services for partners. A core operational advantage is the co-location of Adastra Labs with Chemia Analytics, an in-house licensed analytical testing and consulting laboratory. This integrated facility ensures rigorous quality control, compliance, and efficient product development, emphasizing a scientific and refined approach to extraction methodologies.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release notifying investors of current management arrangements after prior resignations and describing interim roles and the board’s oversight. It clearly pertains to announcements about senior management changes rather than financial results, dividends, or proxy materials. This fits the “Board/Management Information” category.
2025-01-21 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing the date, time, agenda, and proxy voting procedures for the company’s upcoming Annual General Meeting. It summarizes meeting matters and directs shareholders to the proxy and information circular but does not itself constitute the full proxy statement or AGM materials. This is a regulatory news announcement rather than an actual report or detailed filing, so the appropriate category is the general Regulatory Filings (RNS) as a fallback for miscellaneous company announcements.
2024-12-11 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a formal certificate filed with Canadian securities commissions (British Columbia, Alberta, Ontario) under National Instrument 54-101 regarding proxy material mailing timing for an upcoming Annual General Meeting. It is not the AGM materials themselves, nor a management discussion, earnings release, or other standard report. Rather, it is a regulatory compliance filing that does not fit any more specific category, making it a general Regulatory Filing (RNS).
2024-11-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2', which is a standard Canadian regulatory form for the 'Certification of Interim Filings'. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. 9M 2024
2024-11-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” (a CFO certificate under Canadian NI 52-109) rather than the interim financial report or MD&A itself. It does not present financial statements or MD&A content, nor is it an announcement of a report release—it is a regulatory compliance certificate. There is no dedicated category for NI 52-109 certificates, so this falls into the fallback “Regulatory Filings” category.
2024-11-30 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis” for the nine months ended September 30, 2024 and 2023, contains forward-looking statements, discussion of results, risks, and operations, and references compliance with NI 51-102. This matches the definition of a Management Report (MD&A) rather than an interim report, earnings release, or announcement. Therefore, it should be classified as MDA.
2024-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.